Related Experiment Video

Updated: Dec 24, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.4K

Increased Vancomycin Clearance in Patients with Solid Malignancies

Tomohiro Izumisawa1,2, Nobuyuki Wakui3, Tomoyoshi Kaneko2

  • 1Laboratory of Physiological Chemistry, Institute of Medicinal Chemistry, Hoshi University.

Biological & Pharmaceutical Bulletin
|April 17, 2020
PubMed

Insights

Vancomycin (VAN) clearance is higher in solid malignancy patients, leading to lower blood concentrations. Early monitoring of VAN levels in these patients is crucial for effective treatment and preventing side effects.

Area of Science:

  • Pharmacology
  • Oncology
  • Infectious Diseases

Background:

  • Vancomycin (VAN) is a critical antibiotic for bacterial infections but carries a risk of nephrotoxicity.
  • Understanding VAN pharmacokinetics is essential for optimizing therapeutic efficacy and minimizing adverse events.

Purpose of the Study:

  • To investigate pharmacokinetic differences of VAN in Japanese patients with solid malignancy versus non-malignancy patients.
  • To identify if cancer influences VAN clearance and elimination half-life.

Main Methods:

  • Retrospective analysis of VAN trough concentrations in 162 solid malignancy patients and 261 non-malignancy patients.
  • Utilized multiple regression analysis with propensity score adjustment to control for confounding factors.

Main Results:

  • No significant differences in VAN clearance or elimination half-life were initially detected between the two groups.
  • Multiple regression analysis revealed significantly increased VAN clearance in solid malignancy patients across all stages.
  • Solid malignancy was associated with higher VAN clearance, resulting in lower-than-expected blood concentrations.

Conclusions:

  • VAN clearance is significantly increased in patients with solid malignancies.
  • Lower VAN blood concentrations in cancer patients may necessitate adjusted dosing strategies.
  • Proactive monitoring of VAN levels in solid malignancy patients is recommended to ensure therapeutic targets are met and to mitigate toxicity.
Keywords:
multiple regression analysisnon-malignancypharmacokineticssolid malignancyvancomycin

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.3K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.6K

Related Concept Videos

Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
462
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
258
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
150
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
534
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
164